EL7.AI
StocksMedium•26 October 2026•
4 min read

New Mountain Finance Extends $150 Million Share Repurchase Program Through 2027

Key Facts

1The board extended the program through December 31, 2027, from its scheduled end date of December 31, 2026.
2The repurchase authorization is capped at $150 million, and execution is at management’s discretion.
3The company had repurchased about $70 million in shares by the October 26, 2026 announcement.
4New Mountain Finance shares closed at $6.67 on October 23, 2026.

New Mountain Finance extended its share repurchase program through December 31, 2027, from its scheduled end date of December 31, 2026, according to a company statement issued on October 26. The company said its board approved the extension on October 20. The program authorizes the repurchase of up to $150 million in common stock, at management’s discretion. The company said about $70 million in shares had already been repurchased under the program as of the announcement date. The extension adds one year to the period for execution, but does not require the company to repurchase shares or use the full authorized amount.

The previous program, approved by the board on October 23, 2025, permitted repurchases of up to $100 million in shares and was set to expire on December 31, 2026, or when the amount was exhausted, whichever came first. In May 2026, the company announced an additional $50 million authorization, while also reporting that it had repurchased about $66 million in shares since the start of the year through May 1. The weighted average purchase price at the time was $8.01 per share. According to the company’s later announcement, total repurchases under the program had risen to about $70 million by October 26. The new authorization sets a total cap of $150 million, but the disclosure does not say that the full amount will be used.

The company linked the extension to the board’s view that market volatility and continued uncertainty could, from time to time, lead to a decline in the valuation of its shares. In its statement, it said these conditions “may make the company’s common stock undervalued from time to time.” This rationale places the possibility of a lower valuation at the center of the board’s decision, without declaring that the stock is permanently undervalued or setting a target price. The company also did not say that the program extension was intended to manage its capital structure. Under the authorization’s terms, repurchases remain an option available to management within the stated limit, not a recurring obligation or a guaranteed purchase.

The company said the timing of future purchases and the number of shares it may buy will depend on factors including market conditions and alternative investment opportunities. It said management has discretion over the execution of purchases, leaving the decision to use the authorization tied to those factors. The company may make additional purchases through the end of 2027, or may not use the full authorized amount; the statement sets no purchase schedule. The program expires on December 31, 2027, unless the $150 million authorization is exhausted earlier. The extension thus adds time to the existing authorization, while execution remains subject to management’s decision and the conditions cited by the company.

New Mountain Finance is a business development company focused on direct lending to U.S. middle-market companies backed by private equity sponsors. The company says its portfolio consists primarily of senior secured loans, alongside some investments in lower levels of the capital structure. The fair value of its investment portfolio was $2,295.5 million on June 30, 2026, across investments in 113 companies. On the same date, net asset value was $10.89 per share, compared with $10.92 on March 31. This context offers a view of portfolio size and net asset value in the latest available second-quarter disclosures, alongside the extension of the repurchase authorization.

The company’s shares closed at $6.67 on October 23, 2026, according to EL7 data. That closing price compares with net asset value of $10.89 per share on June 30, with the two figures measured on different dates. The extension disclosure does not include a target share price or an estimate of what the company might buy at subsequent market levels. The company also did not specify a date or size for any upcoming purchase. The announced program expiration remains December 31, 2027, though it may end earlier if the authorization cap is exhausted.

Open on chart